This bill, titled the Protecting America's Working Dogs Act of 2026, would require the Attorney General to create a grant program to help cover medical expenses for retired working dogs that served in federal law enforcement, the military, or as service dogs for veterans and retired officers. The program would award grants of up to $575,000 each to eligible nonprofit organizations that primarily care for these dogs and use at least 70 percent of their spending on covered medical costs. Qualified working dogs include retired military working dogs, federal law enforcement dogs, and service dogs for veterans or retired federal law enforcement officers, with grants intended to pay for veterinary care, medical procedures, diagnostics, and necessary medications. The Attorney General would report annually to Congress on the number of dogs assisted and their average medical expenses, while grant amounts would be reduced if previous unspent funds remain.
This bill aims to prevent fraudulent enrollments in health insurance exchanges by requiring the government to check for duplicate social security numbers before issuing premium tax credits. It also mandates that agents and brokers must obtain direct consent from individuals or employers before completing enrollments, rather than accepting third-party attestations of consent. These measures directly affect insurance brokers, agents, and individuals seeking health coverage through federal exchanges. The changes would take effect for plan years beginning on or after January 1, 2027.
This bill directs the Secretary of Health and Human Services to conduct a study on barriers that prevent patients from accessing pain management during gynecologic procedures. The study will examine factors such as insurance coverage, provider training, and resource availability, and will include input from patients, medical professionals, and health equity experts. Within 24 months of enactment, the Secretary must submit a report with findings and recommendations to relevant congressional committees. The bill does not change current laws or funding but establishes a research requirement to inform future policy decisions.
This bill, known as the FAIR Act, would allow the U.S. Food and Drug Administration to approve certain medicines and permit clinical trials for life-threatening diseases more quickly by recognizing approvals from trusted international regulatory authorities. It directly affects drug manufacturers, patients with serious illnesses, and U.S. healthcare providers by creating a new pathway where medicines already approved by agencies like the European Medicines Agency or Health Canada could receive reciprocal marketing approval in the United States. The legislation establishes a 30-day timeline for FDA review of these reciprocal requests and includes provisions for clinical trials authorized abroad, while maintaining safety oversight through withdrawal mechanisms if adverse events occur. The bill specifies that only products intended for immediately life-threatening conditions would qualify under this streamlined process.
The Promoting Dental Health Act extends federal funding for oral health programs through 2031, directly supporting community dental health initiatives and disease prevention efforts. The bill updates the authorization periods for two specific programs under the Public Health Service Act, shifting coverage from previous years to the 2027-2031 timeframe. This reauthorization allows continued government support for oral health promotion activities without requiring new legislation to maintain existing funding streams.
This concurrent resolution formally recognizes Congress's duty to protect the rights and economic security of working women in the United States. It highlights concerns about wage gaps, workplace discrimination, and recent policy changes that the bill's sponsors claim have disproportionately harmed women in the workforce. The document calls for federal action to ensure equal pay, workplace safety, access to healthcare, and the right to unionize, while affirming the importance of women's contributions to the economy. As a non-binding statement of principle, it does not create new laws but serves to express congressional intent and guide future legislative priorities.
This bill would create a federal paid leave program allowing employees to take up to 96 hours of paid time off each year for reproductive health needs, including menstrual care, endometriosis, fertility treatments, and pregnancy-related procedures. It applies to private employers with at least five employees and certain government workers, requiring employers to grant this leave upon request without requiring employees to find replacements during their absence. The legislation prohibits retaliation against employees who use this leave and establishes enforcement mechanisms through the Department of Labor, including civil penalties for violations. Employers with existing paid leave policies that already cover these reproductive health reasons would not need to provide additional leave under this bill.
This bill, known as the Diabetes Foot Health Access and Modernization Act of 2026, makes two main changes to federal health insurance programs. First, it allows podiatric physicians to provide covered physician services under Medicaid, ensuring patients have access to specialized foot and ankle care. Second, it updates Medicare rules to clarify documentation requirements for diabetic shoes, specifying that a physician must confirm a patient has diabetes and related foot conditions before these shoes are covered. The changes take effect on January 1, 2026 for Medicaid podiatry services and January 1, 2028 for Medicare diabetic shoe documentation.
This bill would allow employers of emergency medical technicians and paramedics in rural areas to avoid paying overtime wages under certain conditions. It specifically exempts public agencies in communities with fewer than 100,000 residents and private contractors serving those areas from overtime requirements for these workers. The changes would be made to the Fair Labor Standards Act of 1938, which currently sets federal overtime pay rules. The legislation aims to address staffing challenges in rural emergency medical services by providing flexibility in compensation for these essential workers.
This bill, the PrEP Access and Coverage Act of 2026, requires most health insurance plans to cover HIV prevention medication without charging patients any cost-sharing fees. It directly affects people enrolled in private insurance, Medicare, Medicaid, and other government health programs by mandating that these plans cover the medication, related lab tests, and follow-up care without requiring prior approval. The law also prohibits insurance companies from denying life, disability, or long-term care insurance to individuals taking HIV prevention medication and requires a public education campaign to increase awareness about the medication.